ROCHESTER, N.Y.—Bausch + Lomb, the global eye health company, has named Robert E. Grant chief executive officer and president of its global surgical business, effective Aug. 1.

“Robert is an exceptional leader and innovator in the medical products industry, with global operating expertise extending across devices and pharmaceuticals,” said Brent Saunders, CEO, Bausch + Lomb. “His recruitment is another successful step in the actions we are implementing to transform Bausch + Lomb into a high-performance global competitor,” adding, “He brings a track record of rapid value creation, powerful leadership and a relentless focus on the customer that can take our surgical business to a new level of performance—while also helping us to build strength and execution excellence across the company.”

“I am very excited to join Bausch + Lomb. I am confident that the company will create tremendous value, push product development to new heights, and play a leading role in the future of the global ophthalmic industry,” commented Grant. “With a state-of-the-art product portfolio and a keen focus on the customer, we will lead innovation and growth in this dynamic market segment.”

In 2006, Grant began his tenure as Allergan’s corporate vice president and president, Allergan Medical, where he led the $3.4 billion Allergan-Inamed post-acquisition integration. His leadership at Allergan Medical included the development of the multibillion dollar medical rejuvenation industry through a portfolio of products such as BOTOX Cosmetic, JUVEDERM injectable gel and the LAP-BAND Adjustable Gastric Banding System.

Prior, Grant served as acting chairman, president and CEO of BiolaseTechnology, Inc., the global cosmetic dentistry company, a company he joined in 2003 as chief operating officer and later, CFO. From 1997 to 2003, Grant held management positions with Lumenis, Inc. (formerly Coherent Medical Group), including executive vice president of its Ophthalmic Business Unit, executive vice president of its Surgical Business Unit, vice president of business development and managing director of European Operations. In his new role, he will be based in Aliso Viejo, Calif.

J. Andy Corley, the president of Bausch + Lomb’s Surgical business since 2008, will transition into a role as senior advisor to Brent Saunders and the B+L senior leadership team. “Andy has played a decisive role in building and positioning our Surgical business for future success, and he has also made very important contributions to the evolution of B+L as a whole,” said Saunders. “We thank him for what he has achieved. We will value Andy’s continued advice and counsel as we continue the positive transformation of our company.”